| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 1,490 | 1,490 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ABBOTT LABORATORIES - 400 SHS | 3,662 | 56,296 |
| ABBVIE, INC | 3,971 | 54,160 |
| ALERIAN MLP | 9,623 | 6,548 |
| AMGEN INC - 100 SHS | 1,659 | 22,497 |
| ASSOCIATED BANC CORP | 77,990 | 112,950 |
| BANK OF AMERICA | 22,430 | 44,490 |
| BANK OF MONTREAL | 25,574 | 43,088 |
| BIOGEN | ||
| FISERV | 27,774 | 62,274 |
| PROSHARES ULTRA S&P 500 | 47,570 | 292,740 |
| VANGUARD INTERMEDIATE TF BOND | 51,834 | 52,572 |
| WALGREEN CO. - 200 SHS | 10,557 | 10,432 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| PHILLIPS 66 PARTNERS LP | AT COST | 20,875 | 28,856 |
| WESTERN ASSET ULTRA ST INC FD | AT COST | 100,000 | 98,897 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| ESTIMATED TAXES | 740 | 553 | 553 |
| Description | Amount |
|---|---|
| SUSPENDED PASSIVE LOSS | 1,973 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| OFFICE EXPENSES | 128 | 128 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 338 | 338 | ||
| FEDERAL INCOME TAX | 187 | 187 |